Simultaneous presentation of low-and middle-income countries data for hematologic cancers: a welcome step towards equity
Abstract
Full Text:
PDFReferences
Tehranifar P, Neugut AI, Phelan JC, Link BG, Liao Y, Desai M et al. Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Prevention Biomarkers. 2009;18(10):2701-8.
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang X-S et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977-1010.
Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet. 2010;376(9747):1186-93.
Turkina A, Wang J, Mathews V, Saydam G, Jung CW, Al Hashmi HH et al. TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries. Bri J Haematol. 2020;190(6):869-76.
Hokland P, Shah M, David K, Evens A, Auer R, Ledieu R et al. How I treat advanced Hodgkin lymphoma-a global view. Bri J Haematol. 2020;190(6):837-50.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer J clin. 2018;68(6):394-424.
Torre LA, Siegel RL, Ward EM, Jemal A. Global Cancer Incidence and Mortality Rates and Trends-An Update. Cancer Epidemiol Biomarkers amp; Prevention. 2016;25(1):16-27.
Curado MP, Voti L, Sortino-Rachou AM. Cancer registration data and quality indicators in low and middle income countries: their interpretation and potential use for the improvement of cancer care. Cancer Causes Control. 2009;20(5):751-6.
Wilson C, Tobin S, Young R. The exploding worldwide cancer burden. Int J Gynecol Cancer. 2004;14:1.
Singh GK, Jemal A. Socioeconomic and Racial/Ethnic Disparities in Cancer Mortality, Incidence, and Survival in the United States, 1950-2014: Over Six Decades of Changing Patterns and Widening Inequalities. J Environ Public Health. 2017;2017:2819372.
Heneghan C, Blacklock C, Perera R, Davis R, Banerjee A, Gill P et al. Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification. BMJ open. 2013;3:7.
Phan VH, Tan C, Rittau A, Xu H, McLachlan AJ, Clarke SJ. An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs. Expert opinion drug metabolism toxicol. 2011;7(11):1395-410.
Beran D, Byass P, Gbakima A, Kahn K, Sankoh O, Tollman S et al. Research capacity building 2014;obligations for global health partners. Lancet Global Health. 2017;5(6):e567-e8.
Sharma SK, Choudhary D, Gupta N, Dhamija M, Khandelwal V, Kharya G et al. Cost of hematopoietic stem cell transplantation in India. Mediterranean J Hematol Infect Dis. 2014;6:1.
Bajel A, George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A et al. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol. Pediatr Blood Cancer. 2008;51(5):621-5.
Malhotra P, Yanamandra U, Khadwal A, Prakash G, Lad D, Law AD et al. Autologous stem cell transplantation for multiple myeloma: single centre experience from North India. Indian J Hematol Blood Transfusion. 2018;34(2):261-7.